InvestorsHub Logo
Followers 3
Posts 80
Boards Moderated 0
Alias Born 03/06/2009

Re: None

Monday, 03/22/2010 10:41:36 AM

Monday, March 22, 2010 10:41:36 AM

Post# of 44103
http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20080121005111&newsLang=en

Bederra Corporation completed the acquisition of Diagnos, Inc. in an all-stock transaction. Bederra Corporation issued 15 million restricted common shares of stock for the assets of Diagnosis, Inc.; Diagnos, Inc. will operate as a wholly owned subsidiary of Bederra Corporation. The financial statements issued by the company will reflect the combined financial results. …

…Graham Williams, President of Bederra Corporation, states, “The acquisition of Diagnos, Inc. is the first of many medical related acquisitions planned to enhance our revenues in the coming years.” Projected gross revenues for fiscal year 2008 are anticipated to be in excess of $2.5 million dollars with profits.

** BEDA .167 Per Share Equity Consideration for Valuation from Diagnosis, Inc. Acquisition**

$2,500,000 ÷ 15,000,000 Restricted Shares = .167 Per Share